An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes

Diabetes Care

Volumn 29, Issue 6, 2006, Pages 1237-1241

  Ackermann, Ronald T ^a,f   Marrero, David G ^a   Hicks, Katherine A ^b   Hoerger, Thomas J ^b   Sorensen, Stephen ^c   Zhang, Ping ^c   Engelgau, Michael M ^c   Ratner, Robert E ^d   Herman, William H ^e  

^a INDIANA UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d MEDSTAR RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIET THERAPY; DISEASE COURSE; EXPERIMENTAL MODEL; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PHYSICAL ACTIVITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; TREATMENT OUTCOME;

AGED; COST SHARING; DIABETES MELLITUS; DIET; DISEASE PROGRESSION; EXERCISE; GLUCOSE INTOLERANCE; HEALTH STATUS; HUMANS; LIFE STYLE; MEDICARE; MIDDLE AGED; PROBABILITY; UNITED STATES;

EID: 33746445913     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc05-1709     Document Type: Article

References (19)

1. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, the Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
2. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE, the Diabetes Prevention Program Research Group: The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 142:323-332, 2005
3. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276:1253-1258, 1996
4. Mills RJ: Health insurance coverage: 2000. Consumer income [article online]. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. Available at http://www.census.gov/prod/2001pubs/p60-215. pdf. Accessed 15 January 2004
5. Leatherman S, Berwick D, Iles D, Lewin LS, Davidoff F, Nolan T, Bisognano M: The business case for quality: case studies and an analysis. Health Aff (Millwood) 22:17-30, 2003
6. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 25:2165-2171, 2002
7. The Centers for Disease Control Diabetes Cost-Effectiveness Group: Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287:2542-2551, 2002
8. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
9. Herman WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM, the Diabetes Prevention Program Research Group: Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 26:36-47, 2003
10. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH: The direct medical cost of type 2 diabetes. Diabetes Care 26:2300-2304, 2003
11. The Diabetes Prevention Program Research Group: Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 26:2518-2523, 2003
12. Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH: Valuing health-related quality of life in diabetes. Diabetes Care 25:2238-2243, 2002
13. Public Health Service, National Heart, Lunh, and Blood Institute: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD, National Institutes of Health, 1998 (report no. 98-4083)
14. Task Force on Community Preventive Services: Recommendations to increase physical activity in communities. Am J Prev Med 22 (4 Suppl.):67-72, 2002
15. Jakicic JM, Clark K, Coleman E, Donnelly JE, Foreyt J, Melanson E, Volek J, Volpe SL, the American College of Sports Medicine: American College of Sports Medicine position stand: appropriate intervention strategies for weight loss and prevention of weight regain for adults (Review). Med Sci Sports Exerc 33:2145-2156, 2001
16. McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN: Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 139:933-949, 2003
17. Drummond MF, O'Brien B, Stoddart GL, Torrance GW: Methods for Economic Evaluation of Health Care Programmes. 2nd ed. New York, Oxford University Press, 1997
18. US Department of Health and Human Services: HHS announces revised medicare obesity coverage policy. Available at http://www.hhs.gov/news/press/ 2004pres/20040715.html. Accessed 16 July 2004
19. Centers for Medicare and Medicaid Services: Medicare proposes payment rule to provide new preventive benefits and raise physician payments for 2005. Available at http://www.cms.hhs.gov/media/press/release.asp?Counter 1134. Accessed 27 July 2004